Compare RDCM & INGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RDCM | INGN |
|---|---|---|
| Founded | 1985 | 2001 |
| Country | Israel | United States |
| Employees | N/A | N/A |
| Industry | Computer peripheral equipment | Industrial Specialties |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 205.1M | 172.4M |
| IPO Year | 1999 | 2013 |
| Metric | RDCM | INGN |
|---|---|---|
| Price | $16.07 | $7.03 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $18.00 | $11.25 |
| AVG Volume (30 Days) | 177.4K | ★ 301.7K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 43.42 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $348,668,000.00 |
| Revenue This Year | $11.50 | $8.03 |
| Revenue Next Year | $9.74 | $7.76 |
| P/E Ratio | $16.35 | ★ N/A |
| Revenue Growth | N/A | ★ 3.86 |
| 52 Week Low | $10.41 | $5.34 |
| 52 Week High | $16.49 | $9.13 |
| Indicator | RDCM | INGN |
|---|---|---|
| Relative Strength Index (RSI) | 77.55 | 55.94 |
| Support Level | $12.26 | $6.59 |
| Resistance Level | $16.49 | $7.35 |
| Average True Range (ATR) | 0.74 | 0.34 |
| MACD | 0.27 | 0.01 |
| Stochastic Oscillator | 91.33 | 56.31 |
Radcom Ltd Ltd is engaged in providing network intelligence, 5G ready cloud-native, network intelligence solutions for telecom operators transitioning to 5G. The company has a network intelligence solution for 5G namely Radcom ACE. Its products consist of Radcom Network Visibility, Radcom Service Assurance, and Radcom Network Insights. It has offices in Israel, the United States, Brazil, and India. Key revenue is derived from sales in North America.
Inogen Inc is a medical technology business that focuses on respiratory health. It develops, manufactures, and markets respiratory health products, including portable oxygen concentrators, or POCs, used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions and the Simeox product for airway clearance treatment. In addition, it has started distributing the Inogen Voxi 5 stationary oxygen concentrator as well as the Aurora continuous positive airway pressure, or CPAP, masks in the United States. The company derives revenues from customers through the development, manufacturing, marketing, sales, and rental of respiratory products.